Yongchang Wei
- Biological Psychiatry top 5%
- Tryptophan and brain disorders 5
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 11
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- Behavioral Neuroscience top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 10
- Redox biology and oxidative stress 7
- Genomics, phytochemicals, and oxidative stress 6
-
- Nanoplatforms for cancer theranostics 8
-
- COVID-19 Clinical Research Studies 7
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yongchang Wei
96 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 136
- Biological Psychiatry 82
- Cancer Research 387
- Oncology 467
- Behavioral Neuroscience 50
- Molecular Biology 961
Countries citing papers authored by Yongchang Wei
This map shows the geographic impact of Yongchang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongchang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongchang Wei more than expected).
Fields of papers citing papers by Yongchang Wei
This network shows the impact of papers produced by Yongchang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongchang Wei. The network helps show where Yongchang Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongchang Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 6 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 13 | |
| 13 | The effect of MTHFD2 on the proliferation and migration of colorectal cancer cell lines | 2019 | 1 |
| 14 | 2019 | 34 | |
| 15 | 2018 | 60 | |
| 16 | 2018 | 6 | |
| 17 | 2018 | 8 | |
| 18 | 2017 | 52 | |
| 19 | 2017 | 5 | |
| 20 | 2014 | 49 |
About Yongchang Wei
Yongchang Wei is a scholar working on Biological Psychiatry, Cancer Research and Oncology, having authored 106 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers), Nanoplatforms for cancer theranostics (8 papers), Redox biology and oxidative stress (7 papers), COVID-19 Clinical Research Studies (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Tryptophan and brain disorders (5 papers). The work is most often cited by research in Biological Psychiatry (82 citations), Cancer Research (387 citations) and Oncology (467 citations). Yongchang Wei has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Fuling Zhou, Tianhe Huang, Yunbao Pan, Feng Wang‐Johanning, Kejun Nan, Yu Du, Yanxia Jin, Balu Wu, Gary L. Johanning and Honglei Tu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.